|
Stopping TB in Europe: some progress but still not there
Mercredi 19 Mars 2008 - 19:37 - 9 mois, 3 semaines depuis - Presse spécialisée - Eurosurveillance The latest available information from countries in the World Health Organization (WHO) European Region carries important signals about the tuberculosis (TB) situation in this part of the world. The total number of TB cases reported in the Region was slightly lower in 2006 than in 2005 (422,830 versu... |
|
A Framework Action Plan to fight Tuberculosis in the European Union
Mercredi 19 Mars 2008 - 19:37 - 9 mois, 3 semaines depuis - Presse spécialisée - Eurosurveillance In March 2007 the EU Health Commissioner called on the European Centre for Disease Prevention and Control (ECDC) to work on a proposal for an action plan to fight TB in the EU. Following the call, the ECDC has developed a 'Framework Action Plan to fight Tuberculosis in the European Union'. T... |
|
Demographic features and trends in tuberculosis cases in the European Region, 1995-2005
Mercredi 19 Mars 2008 - 19:37 - 9 mois, 3 semaines depuis - Presse spécialisée - Eurosurveillance In the enlarged European Union (EU-27) and other western countries - where 19% of cases were of foreign origin in 2005 (>50% in 13 countries) - overall TB notification rates decreased by 2.4% yearly between 2000 and 2005, compared to 1.6% in 1995-2000, reflecting a declining incidence in all age ... |
|
The added value of a European Union tuberculosis reference laboratory network analysis of the national reference laboratory activities
Mercredi 19 Mars 2008 - 19:37 - 9 mois, 3 semaines depuis - Presse spécialisée - Eurosurveillance National reference laboratories (NRL) and other laboratories are the cornerstones of well-functioning tuberculosis programmes and surveillance activities. However, the scope and activity of NRL services for mycobacterial identification and drug susceptibility testing (DST) has not been examined in d... |
|
World Health Organization reports highest rates of drug-resistant tuberculosis to date
Mercredi 19 Mars 2008 - 19:37 - 9 mois, 3 semaines depuis - Presse spécialisée - Eurosurveillance On 26 February 2008, the World Health Organization (WHO) published its fourth report on the global situation regarding drug resistance in tuberculosis (TB). The report, based on information collected between 2002 and 2006 on 90,000 TB patients in 81 countries, found that 5.3% of the nine million new... |
|
Travelers Often Fail to Receive Vaccine for Japanese Encephalitis
Mercredi 19 Mars 2008 - 15:04 - 9 mois, 3 semaines depuis - Presse spécialisée - Medscape family medicine In a new survey, only 11% of at-risk travelers reported receiving a Japanese encephalitis virus vaccine. Medscape Medical News |
|
Gene Variant Predicts PTSD After Childhood Abuse
Mercredi 19 Mars 2008 - 14:55 - 9 mois, 3 semaines depuis - Presse spécialisée - Medscape family medicine The risk of adult posttraumatic stress disorder is significantly increased in individuals with genetic risk variants and a history of childhood abuse. Medscape Medical News |
|
FDA Grants Fast Review of Gardasil for Adult Women
Mercredi 19 Mars 2008 - 14:48 - 9 mois, 3 semaines depuis - Presse spécialisée - Medscape family medicine Merck & Co on Wednesday said U.S. regulators have granted a priority review for the company's application to expand marketing of its Gardasil HPV vaccine to women aged 27 through 45. Reuters Health Information |
|
Undiagnosed Primary Immunodeficiency Is a Major Healthcare Burden
Mercredi 19 Mars 2008 - 14:40 - 9 mois, 3 semaines depuis - Presse spécialisée - Medscape family medicine The annual cost of medical care for a patient with undiagnosed primary immunodeficiency syndrome is more than $40,000, investigators reported here at the annual meeting of the American Academy of Allergy, Asthma and Immunology. Reuters Health Information |
|
Undiagnosed Primary Immunodeficiency Is a Major Healthcare Burden
Mercredi 19 Mars 2008 - 14:40 - 9 mois, 3 semaines depuis - Presse spécialisée - Medscape HIV AIDS The annual cost of medical care for a patient with undiagnosed primary immunodeficiency syndrome is more than $40,000, investigators reported here at the annual meeting of the American Academy of Allergy, Asthma and Immunology. Reuters Health Information |
< 1 – 11 – 21 – 31 – 41 – 51 – 61 – 71 – 81 – 91 – 101 – 111 – 121 – 131 – 141 – 151 – 161 – 171 – 181 – 191 – 201 – 211 – 221 – 231 – 241 – 251 – 261 – 271 – 281 – 282 – 283 – 284 – 285 – 286 – 287 – 288 – 289 – 290 – 291 – 292 – 293 – 294 – 295 – 296 – 297 – 298 – 299 – 300 – 301 – 302 – 303 – 304 – 305 – 315 – 325 – 335 – 345 – 355 – 365 >